COVID-19 research campaign moves from basic science to antiviral drug design (IMAGE)
Caption
The drug inhibitor molecule boceprevir, a hepatitis C drug, is combined with GC-376, a chemical warhead from a drug used to treat the original coronavirus outbreak caused by SARS-CoV. The experimental hybrid molecule BBH-1 has shown favorable results in its ability to block the SARS-CoV-2 virus from replicating and preventing it from hijacking healthy human cells.
Credit
ORNL/Jill Hemman
Usage Restrictions
No restrictions.
License
Public Domain